PK-PD Compass

Patent Pending

Make Better Antibiotic Decisions.

iPad and iPhone devices running PK-PD Compass
iPad and iPhone devices running PK-PD Compass
Bottle Right Drug
Pills Right Dose
Clock Right Duration

Establishing a New Frontier in Antimicrobial Stewardship

The PK-PD Compass, a Step Toward Individualized Patient Therapy

Imagine if we could integrate patient demographic, pathogen susceptibility, and PK-PD data, and stewardship documentation into one simple-to-use interface. What if you could carry such a powerful tool in your pocket? We would like to introduce you to the PK-PD Compass, a patent-pending mobile app that allows you to develop PK-PD driven treatment plans.

Infection Pathogen Antibiotics screens

Optimization of Antibiotic Therapy

Make PK-PD a Pillar of Your Antimicrobial Stewardship Practice

Incorporate the science of PK-PD into your daily decisions with the PK-PD Compass, an educational tool designed to augment your antimicrobial stewardship practice through a patient-centric approach.

Results screen 

Sophistication Made Simple

Make Intricate PK-PD Principles Work for You

Behind the scenes, the PK-PD Compass integrates population pharmacokinetics, exposure-response relationships, and pathogen susceptibility data, using Monte Carlo simulation, to evaluate antibiotic regimens through the lens of PK-PD.

SENTRY Region Selection screen 

Harness the Power of a National Susceptibility Surveillance Network

Inform Your Empiric Antibiotic Decisions with SENTRY

Pathogen susceptibility information is often unavailable at the time of initial treatment. Solve this dilemma with data from the SENTRY Antimicrobial Surveillance Program, a database of over 1 million clinical isolates. SENTRY allows you to utilize region-specific susceptibility data to refine your stewardship practice.

Follow-up screen 

Streamline Stewardship Documentation

Save Time and Effort with My Service

Record antimicrobial stewardship events and track your patients’ progress using My Service. Reminders for clinical follow-up at 48 hours and 7-14 days after the start of therapy allow you to document your interventions and resulting patient outcomes.